You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.


Diagnosing and Managing a Patient With Recurring Ocular Issues

  • Authors: Preeya K. Gupta, MD
  • CME / ABIM MOC Released: 3/8/2022
  • Valid for credit through: 3/8/2023, 11:59 PM EST
Start Activity

Target Audience and Goal Statement

This activity is intended for ophthalmologists, primary care physicians, optometrists, and other clinicians who manage patients with neurotrophic keratitis.

The goal of this activity is for clinicians to use best practices for diagnosing and staging neurotrophic keratitis.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Importance of early diagnosis of NK
    • New and emerging therapies for NK
  • Have greater competence related to
    • Strategies for staging NK
  • Demonstrate greater confidence in their ability to
    • Select treatment for NK based on staging


Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.


  • Preeya K. Gupta, MD

    Medical Director and Attending Surgeon
    Triangle Eye Consultants
    Durham, North Carolina


    Disclosure: Preeya K. Gupta, MD, has the following relevant financial relationships:
    Advisor or consultant for: Alcon; Alderya; Allergan; Azura; Expert Opinion; HanAll Biopharma; J&J Vision; Kala; New World Medical; Novartis; Ocular Science; Ocular Therapeutix; Orasis; Oyster Point; Sight Sciences; Spyglass; Sun Pharmaceuticals; Surface Ophthalmics; Tear Clear; Tear Lab; Tissue Tech, Inc.; Visionology; Zeiss
    Stocks, stock options, or bonds from: Expert Opinion; Ocular Science; Orasis; Oyster Point; Spyglass; Surface Ophthalmics; Visionology


  • Pakinam Aboulsaoud, PharmD

    Medical Education Director, WebMD Global, LLC


    Disclosure: Pakinam Aboulsaoud, PharmD, has disclosed no relevant financial relationships.

  • Megan Breuer, PhD

    Medical Writer, WebMD Global, LLC


    Disclosure: Megan Breuer, PhD, has disclosed the following relevant financial relationships: Consultant/Advisor: Paratek Pharmaceuticals (former)

Compliance Reviewer

  • Susan L. Smith, MN, PhD

    Associate Director, Accreditation and Compliance, Medscape, LLC


    Disclosure: Susan L. Smith, MN, PhD, has disclosed no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed the following relevant financial relationships:
Consultant or Advisor: Equinox Ophthalmic, Inc.

Accreditation Statements

Developed through a partnership between Medscape and Postgraduate Institute for Medicine (PIM).


Interprofessional Continuing Education

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 1.0  AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    COPE credit

    Postgraduate Institute for Medicine is accredited by COPE to provide continuing education to optometrists.

    Credit Statement: This course is COPE approved for 1 hours of CE credit. Activity #77375-TD and Course ID 123508. Check with your local state licensing board to see if this counts toward your CE requirement for re-licensure.

    Reviewed by



    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit


There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.


  1. Go to
  2. Login or Create a New Account (will take less than 1 minute)
    1. If you receive a message when creating a new account that “the email you entered is already in use”, please click the Forgot my Username or Password link to have your Username and Password sent to you via email
    2. After logging in, you may be asked to verify/update your information; after doing so, click Save at the bottom of the page
  3. Type in 16960 at the top of the page, “Find Post-Test/Evaluation by Course”, and click enter
  4. Click on the activity title when it appears
  5. Choose the type of credit you desire
  6. Complete the online assessment
  7. Receive an immediate CME/CE Certificate to download and/or print for your files

Diagnosing and Managing a Patient With Recurring Ocular Issues

Authors: Preeya K. Gupta, MDFaculty and Disclosures

CME / ABIM MOC Released: 3/8/2022

Valid for credit through: 3/8/2023, 11:59 PM EST


The following cases are modeled on the interactive grand rounds approach. The questions within the activity are designed to test your current knowledge. After each question, you will be able to see whether you answered correctly and read evidence-based information that supports the most appropriate answer choice. The questions are designed to challenge you; you will not be penalized for answering the questions incorrectly. At the end of the activity, there will be a short post-test assessment based on the material presented.

Case 1: Patient History

Maria is a 38-year-old lawyer who has begun experiencing some recurring ocular issues and is starting to get worried about what they could mean. She has a medical history of allergies, hypertension, and recurring cold sores. She was treated previously with a selective serotonin reuptake inhibitor (SSRI) for depression, and is now in remission. She has a normal body mass index (BMI), and her family and social history is unremarkable. She presents with complaints of red eye and slight blurred vision. She has no complaints of blocked central vision, nor is she seeing spots in her field of vision. Maria also has no issues with closing her eyes or double vision, and her eyelids are not tender or red. She has received antihistamines previously and is currently on antiviral medication.

  • Print